Please login to the form below

Not currently logged in
Email:
Password:

The Partners

This page shows the latest The Partners news and features for those working in and with pharma, biotech and healthcare.

Tox trouble stalls Sosei/Allergan Alzheimer’s drug

Tox trouble stalls Sosei/Allergan Alzheimer’s drug

while the partners investigate the toxicity signal. ... It has already completed another phase 1 study and – according to the partners – has been well-tolerated with no evidence of cancer in around 310 patients treated to date.

Latest news

  • London cancer hub launched by Cancer Research UK London cancer hub launched by Cancer Research UK

    the capital “as new companies are formed, and industry partners move in to translate the most promising discoveries into marketable therapies.”. ... to Australia to help with a marine conservation project on the Great Barrier Reef.

  • Gilead and Galapagos JAK contender scores in RA trial Gilead and Galapagos JAK contender scores in RA trial

    The results are further good news for the partners and their inflammatory conditions contender, which is also being studied in ulcerative colitis, Crohn’s disease and ankylosing spondylitis. ... The new results for filgotinib follow close behind

  • FCB Health Network launch AREA 23 On Hudson FCB Health Network launch AREA 23 On Hudson

    Michael Lieberman will also jointly lead the agency as the executive vice president, executive director, medical/science affairs. ... More and more of our clients were looking for partners to travel with them on the early prelaunch journey, through

  • Boehringer bolts on another immuno-oncology company Boehringer bolts on another immuno-oncology company

    The drugmaker says the viral therapy has shown promising results in combination with its other immuno-oncology programmes. ... We are committed to investing in early research with promise and where our expertise best complements the strengths of our

  • Alnylam gets EU nod for Onpattro amid pricing backlash Alnylam gets EU nod for Onpattro amid pricing backlash

    s Vyndaqel (tafamidis) has been registered in Europe since 2011 and costs in the region of $13, 000 per month. ... on the patient themselves but on their partners and families, many of whom end up being full time carers.”.

More from news
Approximately 1 fully matching, plus 589 partially matching documents found.

Latest Intelligence

  • Cannes Lions Healthcare Agency of the Year – championing change and demanding more… Cannes Lions Healthcare Agency of the Year – championing change and demanding more…

    Brilliant, empathetic, vulnerable; creatives. The spiritual partners to stakeholders across healthcare that deny tradition, champion change and. ... Unpaid carers are the glue that holds healthcare systems together. To doctors they are the partners

  • Trust me, I’m from pharma Trust me, I’m from pharma

    So how is pharma trying to repair the damage of yesterday’s behaviours? ... This fundamentally changes the relationships companies have with their customers; by taking ownership of a broader set of outcomes and aligning incentives more effectively,

  • 30 Women Leaders in UK Healthcare

    direct a team of around 150 scientists at the MSD UK Discovery Centre. ... She also has extensive experience of translating academic research into medical and commercial returns in the UK ecosystem, having worked at UCLPartners and Cambridge University

  • Stepping up in social media: trust and participation are the new imperatives Stepping up in social media: trust and participation are the new imperatives

    For marketers the greatest fascination with digital and social engagement is their ability to be tracked and ‘measured’. ... kind of data they share. Big health brands will have an advantage, while lesser-known companies will need to build  a

  • A quest for innovative solutions A quest for innovative solutions

    A quest for innovative solutions. UCB looks to the future through a PRISM. ... Increase returns. UCB is one of the partners in a consortium that includes other EFPIA companies, universities, research organisations, public bodies, non-profit groups and

More from intelligence
Approximately 0 fully matching, plus 68 partially matching documents found.

Latest appointments

  • Dr Martin Rothman joins Sofinnova Partners Dr Martin Rothman joins Sofinnova Partners

    Dr Martin Rothman joins Sofinnova Partners. He becomes the firm’s venture partner. ... Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners.

  • Unlimited Group appoints group managing director Unlimited Group appoints group managing director

    Unlimited Group appoints group managing director. Michael Richards joins the group from VCCP. ... Richards will head the group’s partners’board and will report into the group Chairman Ian Ferguson.

  • PureTech Health appoints new chief financial officer PureTech Health appoints new chief financial officer

    PureTech Health appoints new chief financial officer. Joep Muijrers joins the biopharma from Life Sciences Partners. ... Muijrers most recently served as a partner and portfolio manager at Life Sciences Partners, a trans-Atlantic investor group with an

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    and the role our members play in developing new innovative medicines and vaccines. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”.

  • Lexington Communications bolsters team with a trio of new-hires Lexington Communications bolsters team with a trio of new-hires

    of the ever-changing health landscape to provide invaluable strategic advise and insider analysis to our existing and potential clients.”. ... Our new senior advisors will join a team that has the reputation of being one of the best in the market, and

More from appointments
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest from PMHub

  • SWITCHED ONcology

    The technologists. The creatives. We unite powerful insights to make science mean something real. ... The campaign provides our partners with deeper insight, smarter ideas and more meaningful innovations, born out of an unprecedented investment into

  • Medical information in precision medicine

    The patient and caregiver populations in the rare disease sector are highly engaged. ... One way of achieving this collaboration is by engaging with patient organisations and clinical trial partners to bring the voice of the customer back into the

  • AMICULUM boosts global healthcare communications offering with a new specialist agency, Seques®

    The Seques brand name and symbol are inspired by DNA sequencing with microarray technology. ... It partners with leading pharmaceutical, biotechnology and medical device companies in some of the most complex and exciting areas of medicine.

  • Sir Bruce Keogh is appointed chair of judges for HSJ Awards

    Andrew Preston, Chief Executive, de Poel health care, which sponsors the awards, said: “ Celebrating the success stories of our partners in healthcare is the reason for supporting the HSJ Awards. ... For further information on the awards and how to

  • WE’s Make Twitter #COUGH campaign awarded with PM Society Bronze

    About:WE works with some of the most innovative companies on the planet — those focused on delivering the next big thing. ... Our playground is consumer, healthcare, social innovation and technology. Our fiercely independent mindset allows us the

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics